Abstract:CD19-specific chimeric antigen receptor T (CAR-T) cell therapy has recently been shown to improve the prognosis of refractory diffuse large B-cell lymphoma (DLBCL). However, CAR-T cells may induce numerous adverse events, in particular cytokine release syndrome (CRS) which is frequently associated with cardiovascular manifestations. Among the latter, acute pericardial effusion represents less than 1% of cases and cardiac tamponade has only been reported once. The management and outcome of these severe complications are not well established. We report here, a case of cardiac tamponade associated with CRS in a context of CAR-T cell therapy, which required urgent pericardiocentesis. Case summary: A 65-year-old man with refractory DLBCL was treated with CAR-T cell therapy. He had a history of dilated cardiomyopathy with preserved ejection fraction and transient atrial fibrillation. A pericardial localization of the lymphoma was observed on the second relapse. One day after CAR-T cell infusion the patient was diagnosed with grade 1 CRS. Due to hypotension, he was treated with tocilizumab and dexamethasone, and then transferred to intensive care unit (ICU). Echocardiography performed at ICU admission showed acute pericardial effusion with signs of right ventricular heart failure due to cardiac tamponade. It was decided to perform pericardiocentesis despite grade IV thrombocytopenia in a context of aplasia. Analysis of pericardial fluid showed a large number of lymphoma cells and 73% of CAR-T cells amongst lymphocytes, a level that was similar in blood. Hemodynamic status improved after pericardiocentesis, and no recurrence of pericardial effusion was observed. The presence of a high count of activated CAR-T cells in the pericardial fluid as well as the short interval between CAR-T cells injection and the symptoms appear as potential arguments for a direct action of CAR-T cells in the mechanism of this adverse event. The patient was discharged from ICU after two days and initially exhibited a good response to DLBCL treatment. Unfortunately, he died fifty days after starting CAR-T cell therapy due to a new DLBCL relapse. Conclusion: Patients with a pericardial localization of DLBCL should be assessed for a risk of cardiac tamponade if receiving CAR-T cell therapy and presenting CRS. In this case, cardiac tamponade seems directly related to CAR-T cell expansion. Pericardiocentesis should be considered as a feasible and effective treatment if the risk of bleeding is well controlled, in association with anti-IL6 and corticosteroids.

[A case of pericarditis carcinomatosa showing good response following local transfer of lymphokine-activated killer (LAK) cells]

Treatment of Patients with Malignant Pleural Effusions Due to Advanced Lung Cancer by Transfer of Autologous LAK Cells Combined with Ril-2 or Ril-2 Alone.

A case of primary cardiac lymphoma located in the pericardial effusion

Curative Effects of Dendritic Cells Combined with Cytokine-Induced Killer Cells in Patients with Malignant Pericardial Effusion

[A Case of Breast Metaplastic Carcinoma and Distant Metastasis with Complete Response to Immunotherapy]

[A case of lung adenocarcinoma with uncontrollable myocardial metastasis and pericardial effusion]

Controlling malignant pericardial effusion by intrapericardial carboplatin administration in patients with primary non-small-cell lung cancer

Case report: CAR-T cell therapy-induced cardiac tamponade

Neuroendocrine carcinoma presenting as cardiac tamponade and dramatic response to steroids

Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion

Isolated Pericardial Effusion Without Associated Myocarditis in a Small-Cell Lung Cancer Patient Undergoing Atezolizumab Therapy

Clinical Observision of Intrapericardial Drug Through Intraducing the Intrapericardial Indwelling Tube in Patients with Malignant Pericardial Effusion

Cardiac Tumor Recurrence After Orthotopic Heart Transplantation In Primary Cardiac Lymphoma

Treatment of malignant pericardial effusion caused by pulmonary malignant tumor with catheter drainage of pericardium and intracavitary administration of interleukin Ⅱ

The diagnosis of primary cardiac lymphoma was facilitated by computed tomographic coronary angiography

Primary cardiac lymphoma: a case report

A Case of Lymphangiomatosis With Infected Lymphangiomas Effectively Treated by Thoracoscopic Debridement and Drainage

Development of adoptive immunotherapy with KK-LC-1-specific TCR-transduced γδT cells against lung cancer cells

[The Cytotoxicity of Malignant Pleural Effusion Lymphocytes and LAK Cells Against Autologous Tumor Cells].

Massive myocardial infiltration by primary anaplastic T-cell lymphoma: a case report

Successful Treatment with Hepatic Arterial Infusion Chemotherapy in a Breast Cancer Patient with Multiple Liver Metastases Who Declined Systemic Therapy